Guo J, He C, Song H, Gao H, Yao S, Dong S
Neurosci Bull. 2024; 40(9):1333-1352.
PMID: 38703276
PMC: 11365900.
DOI: 10.1007/s12264-024-01214-1.
Karcher N, Modi H, Kochunov P, Gao S, Barch D
JAMA Netw Open. 2023; 6(11):e2343081.
PMID: 37955897
PMC: 10644211.
DOI: 10.1001/jamanetworkopen.2023.43081.
Misiak B, Samochowiec J, Kowalski K, Gaebel W, Bassetti C, Chan A
Eur Psychiatry. 2023; 66(1):e58.
PMID: 37476977
PMC: 10486256.
DOI: 10.1192/j.eurpsy.2023.2432.
Kochunov P, Ma Y, Hatch K, Gao S, Acheson A, Jahanshad N
Biol Psychiatry. 2023; 94(4):332-340.
PMID: 36948435
PMC: 10511664.
DOI: 10.1016/j.biopsych.2023.03.009.
Hatch K, Gao S, Ma Y, Russo A, Jahanshad N, Thompson P
Hum Brain Mapp. 2023; 44(6):2636-2653.
PMID: 36799565
PMC: 10028678.
DOI: 10.1002/hbm.26235.
Clinical and cortical similarities identified between bipolar disorder I and schizophrenia: A multivariate approach.
Rootes-Murdy K, Edmond J, Jiang W, Rahaman M, Chen J, Perrone-Bizzozero N
Front Hum Neurosci. 2022; 16:1001692.
PMID: 36438633
PMC: 9684186.
DOI: 10.3389/fnhum.2022.1001692.
Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes.
Puvogel S, Alsema A, Kracht L, Webster M, Weickert C, Sommer I
Mol Psychiatry. 2022; 27(11):4731-4740.
PMID: 36192459
PMC: 9734060.
DOI: 10.1038/s41380-022-01796-0.
Brain-wide versus genome-wide vulnerability biomarkers for severe mental illnesses.
Kochunov P, Ma Y, Hatch K, Gao S, Jahanshad N, Thompson P
Hum Brain Mapp. 2022; 43(16):4970-4983.
PMID: 36040723
PMC: 9582367.
DOI: 10.1002/hbm.26056.
Derivation and utility of schizophrenia polygenic risk associated multimodal MRI frontotemporal network.
Qi S, Sui J, Pearlson G, Bustillo J, Perrone-Bizzozero N, Kochunov P
Nat Commun. 2022; 13(1):4929.
PMID: 35995794
PMC: 9395379.
DOI: 10.1038/s41467-022-32513-8.
Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings.
Cheon E, Bearden C, Sun D, Ching C, Andreassen O, Schmaal L
Psychiatry Clin Neurosci. 2022; 76(5):140-161.
PMID: 35119167
PMC: 9098675.
DOI: 10.1111/pcn.13337.
Separating Clinical and Subclinical Depression by Big Data Informed Structural Vulnerability Index and Its impact on Cognition: ENIGMA Dot Product.
Kochunov P, Ma Y, Hatch K, Schmaal L, Jahanshad N, Thompson P
Pac Symp Biocomput. 2021; 27:133-143.
PMID: 34890143
PMC: 8719281.
DOI: 10.1142/9789811250477_0013.
Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory.
Kochunov P, Fan F, Ryan M, Hatch K, Tan S, Jahanshad N
Hum Brain Mapp. 2020; 43(1):566-575.
PMID: 32463560
PMC: 8675428.
DOI: 10.1002/hbm.25045.
ENIGMA-DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research.
Kochunov P, Hong L, Dennis E, Morey R, Tate D, Wilde E
Hum Brain Mapp. 2020; 43(1):194-206.
PMID: 32301246
PMC: 8675425.
DOI: 10.1002/hbm.24998.
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.
Thompson P, Jahanshad N, Ching C, Salminen L, Thomopoulos S, Bright J
Transl Psychiatry. 2020; 10(1):100.
PMID: 32198361
PMC: 7083923.
DOI: 10.1038/s41398-020-0705-1.
